5.4 Acute Kidney Injury Due to Volume Depletion There have been postmarketing reports of acute kidney injury, in some cases requiring hemodialysis, in patients treated with GLP-1 receptor agonists, BYETTA [see Adverse Reactions (6.2)]
Your provider can discuss whether any of these treatments are appropriate based on your individual goals
The GLP-1 shortage challenges are exacerbated by a lack of accurate, up-to-date, and accessible GLP-1 supply information
The healing and repair formula contains a daily dose of 2.5mg TB-500 with 250mcg BPC-157, to be taken orally between meals
For most, success with psyllium looks like fewer between-meal snacks, steadier appetite, more regular bowel movements, and a small downward drift on the scale over months
Intramuscular injection was not studied in clinical trials